Search Results 381-390 of 20853 for rheumatoid arthritis

  1. Medical Research & Education - Mayo Clinic News Network

    Marla Broadfoot, Ph.D. November 27, 2021. Rheumatoid arthritis finding may lead to new inflammation blockers featured image.

  2. Medical Research & Education - Mayo Clinic News Network

    Advancing precision and predictive medicine in rheumatoid arthritis featured image. Research. Advancing precision and predictive medicine in rheumatoid ...

  3. Medical Research & Education - Mayo Clinic News Network

    Marla Broadfoot, Ph.D. November 27, 2021. Rheumatoid arthritis finding may lead to new inflammation blockers featured image.

  4. Kenneth T. Calamia, M.D. - Doctors and Medical Staff - Mayo Clinic

    Vasculitis · Behcet's disease · General rheumatology · Rheumatoid arthritis · Pulmonary hypertension in rheumatic diseases · Retroperitoneal fibrosis ...

  5. Arthritis - Doctors and departments - Mayo Clinic

    Hand exercises for people with arthritis · Joint protection for people with hand arthritis · Osteoarthritis versus rheumatoid arthritis. Show more related ...

  6. Cynthia S. Crowson, Ph.D. - Mayo Clinic Faculty Profiles

    ... rheumatoid arthritis and other rheumatic diseases. Evaluating long-term outcomes and identifying patient subgroups with the worst outcomes are key steps ...

  7. Medical Research & Education - Mayo Clinic News Network

    Marla Broadfoot, Ph.D. November 27, 2021. Rheumatoid arthritis finding may lead to new inflammation blockers featured image.

  8. Adalimumab-aaty (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-aaty injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...

  9. Arthritis - Doctors and departments - Mayo Clinic

    Rheumatologist. Jacksonville, FL. Areas of focus: Rheumatoid arthritis, Gout, Vasculitis, Behcet disease ... Ultrasound, Rheumatoid arthritis, Psoriatic arthritis ...

  10. A Study Of CNTO 136 (Sirukumab), A Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, In Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    The purpose of this study is to assess the efficacy of sirukumab as measured by the reduction of the signs and symptoms of rheumatoid arthritis (RA) in patients ...